期刊文献+

不同钙浓度透析液对维持性血液透析患者血甲状旁腺素及钙磷代谢的影响 被引量:3

Influence of Calcium Concentration in Dialysate on Calcium,Phosphate and Parathyroid Hormone for Hemodialysis Maintaining Patient
下载PDF
导出
摘要 目的研究不同钙浓度透析液对血液透析患者钙磷代谢及甲状旁腺素(iPTH)的影响。方法 30例维持性血液透析患者随机分为3组,分别采用钙浓度1.25、1.5mmol/L及1.75mmol/L透析液连续进行3个月血液透析治疗,此期患者饮食中钙磷的摄入量稳定,用药不变。实验前检测透析前血iPTH,透析前后血钙和血磷浓度。3个月后复查透析前血iPTH,透析前后血钙和血磷浓度。结果观察结束时DCa1.25、DCa1.5和DCa1.75组,血清Ca×P水平:DCa1.25组血清Ca×P水平明显降低(P<0.01)、DCa1.5组无变化、DCa1.75组升高(P<0.05);iPTH水平:DCa1.25组显著升高(P<0.01),DCa1.5组升高(P<0.05),DCa1.75组降低(P<0.05)。结论高钙透析可增加透析患者的钙负荷及转移性钙化的发生,低钙透析可在有限时间内减轻高钙负荷,但长期应用低钙透析液应监测iPTH水平。 Objective To study the affection of varied calcium concentration in dialysis fluid for calcium and phosphate metabolism, and parathyroid of hemodialysis patient.Methods 30 cases of such patientwere divided into 3 groups.The varied calcium concentration fluid of 1.25,1.5 and 1.75mmol/Lwas given in hemodialysis for 3 months.During this peried,the patientsmaintained stable for diet and medication.The Ca,P,iPTH were detected before furthertherapy and were compared. Results The CaXP level was decreased in DCa 1.25 group, no change in 1.5 group and increased in 1.75 group.The iPTH level was increased in DCa 1.25 group, l.5 group and decreased in 1.75 group.Conclusion The high concentration of calcium in dialysis fluid might increase the calcium load and transverse calcium happening.The low calcium concentration might decrease calcium load,but monitoring of iPTH level should be taken.
机构地区 沭阳县中医院
出处 《中外医疗》 2012年第2期13-14,共2页 China & Foreign Medical Treatment
关键词 低钙透析 血液透析 钙磷代谢 甲状旁腺素 Low calcium dialysis s Hemodialysis ~ Calcium and phosphate metabolism Parathyroid
  • 相关文献

参考文献6

二级参考文献25

  • 1孙鲁英,左力,王梅.不同钙离子浓度透析液对血液透析患者钙平衡及甲状旁腺素的影响[J].中华肾脏病杂志,2004,20(3):210-213. 被引量:51
  • 2汤学宇,吴冬英,陈燕芳,熊勇,赵中苏,谢吉玉,李维.高钙透析液对透析中低血压患者血压的影响[J].中国血液净化,2004,3(10):558-559. 被引量:13
  • 3De Vries JPPM, Kouw PM, van der Meer NJM. Non-invasive monitoring of blood volume during hemodialysis: Its relation with post-dialytic dry weight. Kidney Int, 1993, 44: 851.
  • 4Catherine C, Philippe M, Didier B. Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67 citrate associated with hypercalcemia. Clin Nucl Med, 2003, 28: 467-471.
  • 5Argilés A, Mourad G. How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism? Nephrol Dial Transplant, 1998, 13 Suppl 3:62-64.
  • 6Palmer, Biff F. Individualizing the dialysate in the hemodialysis patient. Semin Dial, 2001, 14: 41-49.
  • 7Hou SH, Zhao J, Ellman CF, et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis,1991, 2: 217-224.
  • 8Argilés A, Kerr PG, Canaud B, et al. Hemodialysis and hemodiaffitration Ca kinetics, and the long-term effects of lowering dialysate calcium concentration. Kidney Int, 1993, 43: 630-640.
  • 9Yudd M, Liach F. Renal osteodystrophy. In: Brenner BM, ed.Dialysis and transplantation. 北京: 科学出版社, 2001.14:259-260.
  • 10Argilés A, Mion CM. Calcium balance and intact parathormone variations during haemodiafiltration. Nephrol Dial Transplant,1995, 10: 2083-2089.

共引文献90

同被引文献8

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部